Denali Therapeutics
BiotechnologySan Francisco, California, United StatesPost-IPO Debt$1.3B total fundingwww.denalitherapeutics.com
Latest funding:$200.0M · Post-IPO Debt (December 4, 2025)
Angel investors who backed Denali Therapeutics
21 investors in our database backed Denali Therapeutics.
Ignacio Martinez
Chairman
Avak Kahvejian
Chairman of the Board
Harry Wilcox
General Partner
Eytan Weinstein
Research Software Engineer
Nick Plugis
Senior Principal
Ewen Cameron
Operating Partner
Sabrina Yang
Chief Innovation Officer
Nathan Stebbins
Principal
Douglas Cole
Managing Partner
Stephen Berenson
Chairman of the Board
Chuck Carelli
Chief Financial Officer
Torben Straight Nissen
Executive Partner
Alex Goldsmith
Vice President, Global Scientific Engagement
Jacob Rubens
President
Molly Gibson
Origination Partner
Noubar Afeyan
Founder and CEO
Jim Gilbert
Senior Partner
David Berry
General Partner
Theonie Anastassiadis
Senior Associate
Boris Nikolic
Managing Director
Julie Sunderland
Managing Director
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Denali Therapeutics.
Search investors